FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE

FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE was reported 2414 times

FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 REACTION TO SWEETENER 3 0.0909
1 OESOPHAGEAL MUCOSA ERYTHEMA 1 0.0238
2 ACCIDENTAL EXPOSURE TO PRODUCT PACKAGING 3 0.0127
3 PRODUCT AFTER TASTE 9 0.0094
4 LOSS OF BLADDER SENSATION 1 0.0061
5 RENAL HAEMANGIOMA 3 0.0038
6 BIPOLAR II DISORDER 1 0.0028
7 SPHINCTER OF ODDI DYSFUNCTION 1 0.0024
8 DRUG EFFECT LESS THAN EXPECTED 34 0.0023
9 REBOUND ACID HYPERSECRETION 6 0.0020
10 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 2 0.0019
11 HYPERPARATHYROIDISM SECONDARY 4 0.0016
12 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 1 0.0011
13 NEPHROGENIC ANAEMIA 5 0.0011
14 NASAL INFLAMMATION 1 0.0009
15 THERAPEUTIC PRODUCT EFFECT DELAYED 4 0.0009
16 END STAGE RENAL DISEASE 14 0.0008
17 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 4 0.0007
18 CHRONIC KIDNEY DISEASE 53 0.0007
19 RENAL INFARCT 1 0.0007
20 GENERALISED ANXIETY DISORDER 1 0.0007
21 BLADDER SPASM 1 0.0005
22 HYPERCHLORHYDRIA 3 0.0005
23 MULTI-ORGAN DISORDER 1 0.0005
24 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 3 0.0005
25 JAW FRACTURE 1 0.0005
26 RENAL TUBULAR ACIDOSIS 1 0.0005
27 APHTHOUS STOMATITIS 1 0.0004
28 REACTION TO EXCIPIENT 1 0.0004
29 EXPIRED PRODUCT ADMINISTERED 14 0.0004
30 WEIGHT ABNORMAL 1 0.0004
31 LARYNGOSPASM 1 0.0004
32 UPPER RESPIRATORY TRACT CONGESTION 1 0.0003
33 NEPHROPATHY 3 0.0003
34 RENAL INJURY 9 0.0003
35 NEPHRITIS 1 0.0003
36 INCORRECT PRODUCT ADMINISTRATION DURATION 6 0.0003
37 TOOTH FRACTURE 3 0.0003
38 CARDIOPULMONARY FAILURE 1 0.0003
39 SOCIAL PROBLEM 1 0.0002
40 TUBULOINTERSTITIAL NEPHRITIS 4 0.0002
41 SKIN TIGHTNESS 1 0.0002
42 RENAL FAILURE 27 0.0002
43 DIABETIC NEUROPATHY 1 0.0002
44 TOE AMPUTATION 1 0.0002
45 PHLEBITIS 1 0.0002
46 MALABSORPTION 1 0.0002
47 GASTROOESOPHAGEAL REFLUX DISEASE 15 0.0002
48 PRODUCT SIZE ISSUE 1 0.0002
49 CYSTIC FIBROSIS 1 0.0002
50 EXERCISE TOLERANCE DECREASED 1 0.0002
51 SCOLIOSIS 1 0.0002
52 ACUTE KIDNEY INJURY 23 0.0002
53 DYSGEUSIA 11 0.0001
54 PRODUCT LABEL ISSUE 1 0.0001
55 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 1 0.0001
56 ORAL DISCOMFORT 2 0.0001
57 INCORRECT DRUG ADMINISTRATION DURATION 4 0.0001
58 MAJOR DEPRESSION 1 0.0001
59 ESCHERICHIA INFECTION 1 0.0001
60 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
61 OROPHARYNGEAL DISCOMFORT 1 0.0001
62 PRODUCT PACKAGING ISSUE 1 0.0001
63 RENAL TUBULAR NECROSIS 1 0.0001
64 INABILITY TO AFFORD MEDICATION 1 0.0001
65 DRUG ADMINISTRATION ERROR 3 0.0001
66 EAR DISCOMFORT 1 0.0001
67 RENAL IMPAIRMENT 8 0.0001
68 BODY HEIGHT DECREASED 1 0.0001
69 TOOTH DISORDER 2 0.0001
70 THERAPEUTIC RESPONSE UNEXPECTED 4 0.0001
71 REBOUND EFFECT 1 0.0001
72 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 6 0.0001
73 UNDERDOSE 6 0.0001
74 ILEUS 1 0.0001
75 GASTRIC CANCER 2 0.0001
76 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
77 SKIN REACTION 1 0.0001
78 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 14 0.0001
79 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
80 THROAT IRRITATION 3 0.0001
81 CORONARY ARTERY DISEASE 2 0.0001
82 DELUSION 1 0.0001
83 DRUG INEFFECTIVE 81 0.0001
84 MANIA 1 0.0001
85 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
86 MUSCULOSKELETAL DISCOMFORT 1 0.0001
87 PARANOIA 1 0.0001
88 HYPERKALAEMIA 2 0.0001
89 GASTROENTERITIS VIRAL 1 0.0001
90 TOOTHACHE 1 0.0001
91 OSTEOMYELITIS 1 0.0001
92 PHOTOPHOBIA 1 0.0001
93 FOOT FRACTURE 1 0.0001
94 INCORRECT DOSE ADMINISTERED 12 0.0001
95 HERNIA 1 0.0001
96 ERUCTATION 1 0.0001
97 KNEE ARTHROPLASTY 1 0.0000
98 HALLUCINATION, VISUAL 1 0.0000
99 RETCHING 1 0.0000
100 POOR QUALITY SLEEP 1 0.0000
101 FAECES DISCOLOURED 1 0.0000
102 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
103 ORAL PAIN 1 0.0000
104 ABDOMINAL PAIN UPPER 9 0.0000
105 RENAL DISORDER 2 0.0000
106 OCULAR HYPERAEMIA 2 0.0000
107 MIGRAINE 4 0.0000
108 PRODUCTIVE COUGH 2 0.0000
109 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
110 LUNG DISORDER 2 0.0000
111 DYSPEPSIA 4 0.0000
112 AGEUSIA 1 0.0000
113 PRODUCT COMPLAINT 1 0.0000
114 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
115 JOINT STIFFNESS 1 0.0000
116 GASTRITIS 1 0.0000
117 PANCREATITIS 2 0.0000
118 DRUG EFFECT DECREASED 2 0.0000
119 THROAT TIGHTNESS 1 0.0000
120 FEELING COLD 1 0.0000
121 ABDOMINAL DISCOMFORT 6 0.0000
122 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
123 FLATULENCE 2 0.0000
124 DYSSTASIA 1 0.0000
125 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
126 LABORATORY TEST ABNORMAL 1 0.0000
127 MATERNAL EXPOSURE DURING PREGNANCY 3 0.0000
128 BLOOD POTASSIUM DECREASED 1 0.0000
129 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
130 SWOLLEN TONGUE 1 0.0000
131 MOOD SWINGS 1 0.0000
132 DEPRESSION 7 0.0000
133 NEOPLASM MALIGNANT 2 0.0000
134 EYE PRURITUS 1 0.0000
135 TYPE 2 DIABETES MELLITUS 1 0.0000
136 ILLNESS 3 0.0000
137 ABDOMINAL DISTENSION 3 0.0000
138 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
139 DRUG EFFECT INCOMPLETE 1 0.0000
140 RESTLESSNESS 1 0.0000
141 CONDITION AGGRAVATED 8 0.0000
142 OFF LABEL USE 22 0.0000
143 EXTRA DOSE ADMINISTERED 1 0.0000
144 DRY MOUTH 2 0.0000
145 ANXIETY 7 0.0000
146 CARDIO-RESPIRATORY ARREST 1 0.0000
147 RECTAL HAEMORRHAGE 1 0.0000
148 GASTROINTESTINAL DISORDER 2 0.0000
149 OROPHARYNGEAL PAIN 2 0.0000
150 CHEST PAIN 4 0.0000
151 HYPERSENSITIVITY 4 0.0000
152 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1 0.0000
153 DISEASE RECURRENCE 1 0.0000
154 RENAL CANCER 1 0.0000
155 HEART RATE INCREASED 2 0.0000
156 AGGRESSION 1 0.0000
157 HOSPITALISATION 3 0.0000
158 NERVOUSNESS 1 0.0000
159 HYPERTENSION 4 0.0000
160 RASH PRURITIC 1 0.0000
161 CONSTIPATION 4 0.0000
162 EYE PAIN 1 0.0000
163 PRODUCT SUBSTITUTION ISSUE 1 0.0000
164 BONE PAIN 1 0.0000
165 CHILLS 2 0.0000
166 NASAL CONGESTION 1 0.0000
167 WHEEZING 1 0.0000
168 ILL-DEFINED DISORDER 1 0.0000
169 NAUSEA 13 0.0000
170 MALAISE 7 0.0000
171 LOSS OF CONSCIOUSNESS 2 0.0000
172 AMNESIA 1 0.0000
173 DEVICE DIFFICULT TO USE 1 0.0000
174 FEBRILE NEUTROPENIA 1 0.0000
175 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
176 BURNING SENSATION 1 0.0000
177 SLEEP DISORDER 1 0.0000
178 DYSPNOEA 8 0.0000
179 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
180 DIARRHOEA 9 0.0000
181 BRONCHITIS 1 0.0000
182 HALLUCINATION 1 0.0000
183 UNEVALUABLE EVENT 1 0.0000
184 VOMITING 6 0.0000
185 INJECTION SITE BRUISING 1 0.0000
186 CARDIAC FAILURE 1 0.0000
187 CARDIAC FAILURE CONGESTIVE 1 0.0000
188 INFLUENZA LIKE ILLNESS 1 0.0000
189 CARDIAC ARREST 1 0.0000
190 TREMOR 2 0.0000
191 DIZZINESS 6 0.0000
192 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
193 URTICARIA 2 0.0000
194 MYALGIA 2 0.0000
195 URINARY TRACT INFECTION 2 0.0000
196 INTENTIONAL PRODUCT MISUSE 1 0.0000
197 INSOMNIA 3 0.0000
198 HEADACHE 7 0.0000
199 ADVERSE DRUG REACTION 1 0.0000
200 SUICIDAL IDEATION 1 0.0000
201 MUSCLE SPASMS 2 0.0000
202 ADVERSE EVENT 1 0.0000
203 BREAST CANCER 1 0.0000
204 SWELLING 1 0.0000
205 BLOOD GLUCOSE INCREASED 2 0.0000
206 CONTUSION 1 0.0000
207 FLUSHING 1 0.0000
208 SINUSITIS 1 0.0000
209 PLATELET COUNT DECREASED 1 0.0000
210 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
211 ASTHMA 1 0.0000
212 DECREASED APPETITE 2 0.0000
213 PALPITATIONS 1 0.0000
214 FEELING ABNORMAL 2 0.0000
215 JOINT SWELLING 1 0.0000
216 DRY SKIN 1 0.0000
217 MEMORY IMPAIRMENT 1 0.0000
218 WEIGHT DECREASED 2 0.0000
219 RASH 3 0.0000
220 PRODUCT DOSE OMISSION ISSUE 2 0.0000
221 HYPOAESTHESIA 1 0.0000
222 BLOOD PRESSURE INCREASED 1 0.0000
223 PERIPHERAL SWELLING 1 0.0000
224 FATIGUE 5 0.0000
225 CONFUSIONAL STATE 1 0.0000
226 CEREBROVASCULAR ACCIDENT 1 0.0000
227 DEATH 5 0.0000
228 COVID-19 1 0.0000
229 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
230 PRURITUS 2 0.0000
231 SOMNOLENCE 1 0.0000
232 ARTHRALGIA 2 0.0000
233 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
234 COUGH 1 0.0000
235 PAIN IN EXTREMITY 1 0.0000
236 INJECTION SITE PAIN 1 0.0000
237 PAIN 2 0.0000
238 PNEUMONIA 1 0.0000
239 FALL 1 0.0000
240 PYREXIA 1 0.0000
241 ASTHENIA 1 0.0000